期刊文献+

环氧化酶2和基质金属蛋白酶7在喉癌中的表达 被引量:1

Expression and their clinical significance of COX-2 and MMP-7 in laryngeal squamous cell carcinoma
下载PDF
导出
摘要 目的探讨环氧化酶2(cycloxygenase-2,COX-2)和基质金属蛋白酶7(matrix metalloprotei- nase-7,MMP-7)在喉鳞状细胞癌(简称喉癌)组织中的表达及临床意义。方法采用免疫组化SP法检测65例喉癌组织及34例癌旁组织中COX-2和MMP-7的表达情况。结果COX-2和MMP-7在LSCC组织中的阳性表达率分别为72.3%和75.4 %,与癌旁组织比较(20.6%,23.5%),其表达均显著增高(P<0.05),且COX-2和MMP-7的表达呈正相关(P<0.05)。两者的表达水平随临床分期的进展显著增高(P<0.05)。COX-2阳性表达组总生存率和无瘤生存率较COC-2阴性表达组明显降低(P<0.05)。结论喉癌组织中存在COX-2和MMP-7的过度表达,其促进了喉癌的发生和侵袭,两者在喉癌发生和进展过程中可能存在协同作用,COX-2的过度表达提示预后不良。 OBJECTIVE To investigate the expression of cycloxygenase-2 (COX-2) and matrix metalloproteinase-7 (MMP-7) in laryngeal squamous cell carcinoma (LSCC) and their clinical significance. METHODS The expression of COX-2 and MMP-7 in 65 LSCC tissues and 34 adjacent non-neoplastic tissues were studied by immunohistochemical SP method. RESULTS The expression of COX-2 and MMP-7 was observed in 72.3 % and 75.4 % of the LSCC tissues and in 20.6 % and 23.5 % of the adjacent nonneoplastic tissues respectively, which had a significant difference (P〈 0.05). In addition, there was a significant positive correlation between the expression of COX-2 and MMP-7 (P〈 0.05). The expression of COX-2 and MMP-7 was positively correleted with the advancement of clinical staging (P〈 0.05). Kaplan-Meier survival curve showed that the prognosis of COX-2 positive group was poorer than negative group (P〈 0.05). CONCLUSION The overexpression of COX-2 and MMP-7 was observed in LSCC tissues, which might play a crucial role in the oncogenesis and invasion of the LSCC. There might be a synergistic effect in the process of tumor development between them. The overexpression of COX-2 in LSCC predicts a poor prognosis.
出处 《中国耳鼻咽喉头颈外科》 北大核心 2008年第3期126-129,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 四川省应用基础研究资助项目(05JY029-104)
关键词 喉肿瘤 鳞状细胞 环氧化合物 基质金属蛋白酶类 免疫组织化学 Laryngeal Neoplasms Carcinoma, Squamous cell Epoxy Compounds Matrix Metalloproteinases Immunohistochemistry
  • 相关文献

参考文献9

  • 1[1]Volm M,Koomagi R,Matten J.Prognostic value of vascular endothelial growth factor and its receptor Fit-1 in squamous celllung cancer.Int J Cancer,1997,74:64-68.
  • 2杨立,覃纲,王力红,梁传余,刘世喜.环氧化酶-2及其抑制剂与头颈部鳞状细胞癌[J].国际耳鼻咽喉头颈外科杂志,2007,31(3):166-169. 被引量:2
  • 3[3]Kawata R,Hyo S,Maeda T,et al.Simultaneous expression of cyclooxygenase-2 and microsomal prostaglandin E synthase in squamous cell carcinoma of the larynx.Acta Otolaryngol,2006.126:627-632.
  • 4[4]Shishodia S,Aggarwal BB.Cyclaoxygenase(COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor(NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma:correlation with suppression of cyclin D1,COX-2,and matrixmetalloproteinase-9.Cancer Res,2004,64:5004-5012.
  • 5孙亚男,王小红,邓焕珍,李源,刘小华,金德均,李鹏.基质金属蛋白酶-7与喉鳞癌浸润转移及预后评估的相关性(英文)[J].中国临床康复,2005,9(14):195-197. 被引量:2
  • 6[8]Xie M,Sun Y,Li Y.Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases.Laryngoscope,2004,114:2243-2248.
  • 7[9]Sun WH,Sun YL,Fang RN,et al.Expression of cyclooxyge-nase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.Jpn J Clin Oncol,2005,35:707-713.
  • 8[10]Nosho K,Yoshida M,Yamamoto H,et al.Association of Ets-related transc riDtionaI factor ElAF expression with Overexpression of matrix metalIoproteinases,COX-2 and iNOS in the early stage of colorectal carcinogenesis.Carcinogenesis,2005,26:892-899.
  • 9[11]Blackhall FH,Shepherd FA.Small cell lung cancer and targeted therapies.Curr Opin Oncol,2007,19:103-108.

二级参考文献12

  • 1Chun-YingWu,Chau-JongWang,Chi-ChuanTseng,Hsiao-PingChen,Ming-ShingWu,Jaw-TownLin,HiroyasuInoue,Gran-HumChen.Helicobacter pyloripromote gastric cancer cells invasion through a NF-κB and COX-2-mediated pathway[J].World Journal of Gastroenterology,2005,11(21):3197-3203. 被引量:31
  • 2Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their role in tumor invasion and metastasis. Eur J Cancer 2000; 36:1621 -30.
  • 3Zeng ZS, Shu WP, Cohen AM, et al. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation n human cancer metastases. Clin Cancer Res 2002; 8:144 - 8.
  • 4Crawford HC, Scoggins CR, Washington MK, et al. Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 2002; 109( 11 ): 1437 - 44.
  • 5Huo N, Ichikawa Y, Kamiyama M, et al. MMP-7(MMP-7) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 2002; 177(1):95 - 100.
  • 6Fukushima H, Yamamoto H, Itoh F, et al. Association of matrilysin mRNA expression with K-ras mutations and progression in pancreatic ductal adenocarcinomas. Carcinogenesis 2001; 22:1049 - 52.
  • 7Shiomi T, Okada Y. MT1 -MMP and matrilysin in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003; 22 (2 - 3 ): 145 - 52.
  • 8Imai K, Yokohama Y, Nakanishi 1, et al. Matrix metalloproteinase 7 ( MMP-7 ) from human rectal carcinoma ceils: Activation of the precursor interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 1995; 270:6691 -7.
  • 9Barille S, Bataille R, Rapp M J, et al. Production of metalloproteinase-7(matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J Immunol 1999; 163:5723 - 8.
  • 10Yamamoto H, Adachi Y, Itoh F, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 1999;59(14):3313-6.

共引文献2

同被引文献11

  • 1钱敏飞,王家东,郑璐滢.p27、p53和Bcl-2蛋白在喉癌和切缘组织中的表达[J].中国耳鼻咽喉头颈外科,2005,12(11):721-724. 被引量:5
  • 2Nowee Me, Dorsman JC, Piek JM, et al. HER-2/neu and p27kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study. Histopathology, 2007, 51: 666-673.
  • 3Urade M. Cyclooxygenase (COX)-2 as a potent molecular target for prevention and therapy of oral cancer. Japanese Dental Science Review, 2008, 44: 57-65.
  • 4Gallo O, Masini E, Bianchi B, et al. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol, 2002, 33: 708-714.
  • 5Kawata R, Hyo S, Araki M, et al. Expression of cyclooxygenase-2 and microsomal prostagalandin E synthase-1 in head and neck squamous cell carcinoma. Auris Nasus Larynx, 2010, 37: 482-487.
  • 6Hussein MR, Haemel AK, Wood GS. p53-related pathways and the molecular pathogenesis of melanoma. Eur J Cancer Prev, 2003, 12: 93-100.
  • 7Ohnishi K, Ota I, Takahashi A, et al. Transfection of mutant p53 gene depresses X-ray- or CDDP-induced apoptosis in a human squamous cell carcinoma of the head and neck. Apoptosis, 2002, 7: 367-372.
  • 8Lin Y, Lu Z, Kokontis J, et al. Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression. Biochemical Biophys Res Commun, 2013, 430: 289-293.
  • 9Maurizi M, Scambia G, Benedetti Panici P, et al. EGF receptor expression in primary laryngeal cancer: correlation with clinicopathologicaI features and prognostic significance. Int J Cancer, 1992, 52: 862-866.
  • 10谌敏峰,梁传余,覃纲,刘吉峰,周莲.PCNA和COX-2在喉鳞状细胞癌中的表达及意义[J].西部医学,2009,21(2):188-191. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部